Erliso 1mg Injection 10ml is a fabricated equivalent of vasopressin utilized to manage hepatorenal syndrome. It functions by activating V1 receptors in the vascular smooth muscle, provoking vasoconstriction, which enhances blood circulation to critical organs. Furthermore, it reduces portal tension in the liver, handling issues associated with cirrhosis.

• This treatment will be managed by your physician or nurse.
• Absolutely refrain from self application.
• Depend on medical experts for precise measurement and usage.
• Follow your physician or nurse's instruction to guarantee the secure and efficient use of this treatment.

• Use with caution in patients with heart conditions.
• Monitor blood pressure closely during therapy.
• Assess renal function regularly.
• Avoid in pregnancy unless benefits outweigh risks.
• Be cautious in patients with known allergies to Terlipressin.

• Acts as a potent vasopressor.
• Enhances stability in cardiovascular function.
• Used to control bleeding from esophageal varices.
• Beneficial in addressing hepatorenal syndrome.
• Supports the regulation of blood flow.

• Ischemia
• Abdominal pain
• Diarrhea
• Nausea
• Slow heart rate
• Breathlessness
• Pleural effusion
• Respiratory failure
• Fluid overload